Vulnerabilities

Vulnerability · CVE-2025-38386

In the Linux kernel, the following vulnerability has been resolved: ACPICA: Refuse to evaluate a method if arguments are missing As reported in [1], a platform firmwar…

Published Jul 25, 2025 · catalog updated Oct 15, 2026 · linux kernel

Check if you run it

No confirmed exploitation is on record for CVE-2025-38386. EPSS is 0.20%. Act only if a listed version of linux kernel is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Medium5.5
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.20%
Remediation
Advisory link
Affected products
cpe debian/debian linux · cpe linux/linux kernel

In the Linux kernel, the following vulnerability has been resolved: ACPICA: Refuse to evaluate a method if arguments are missing As reported in [1], a platform firmware update that increased the number of method parameters and forgot to update a least one of its callers, caused ACPICA to crash due to use-after-free. Since this a result of a clear AML issue that arguably cannot be fixed up by the interpreter (it cannot produce missing data out of thin air), address it by making ACPICA refuse to evaluate a method if the caller attempts to pass fewer arguments than expected to it.

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • cpe debian/debian linux11.0
  • cpe linux/linux kernel6.16

How to fix CVE-2025-38386

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-38386. EPSS is 0.20%. Act only if a listed version of linux kernel is installed.

Which versions are affected?

Compare what you have installed with debian/debian linux 11.0; linux/linux kernel 6.16. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

CWE-416: Use After Free. EPSS 0.20%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

Timeline

Detection, updates, and resolution for this record.

  1. Jul 25, 2025 · NIST NVD

    Detected

    In the Linux kernel, the following vulnerability has been resolved: ACPICA: Refuse to evaluate a method if arguments are missing As reported in [1], a platform firmware update that increased the number of method parameters and forgot to update a least one of its callers, caused ACPICA to crash due to use-after-free. Since this a result of a clear AML issue that arguably cannot be fixed up by the i

  2. Oct 15, 2026 · NIST NVD

    Updated

    In the Linux kernel, the following vulnerability has been resolved: ACPICA: Refuse to evaluate a method if arguments are missing As reported in [1], a platform firmware update that increased the number of method parameters and forgot to update a least one of its callers, caused ACPICA to crash due to use-after-free. Since this a result of a clear AML issue that arguably cannot be fixed up by the i

Sources

  • CVE.orgVulnerability recordCVE-2025-38386

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-38386

    30-day exploitation probability 0.2%

    first.org
  • NIST NVDVulnerability recordCVE-2025-38386

    In the Linux kernel, the following vulnerability has been resolved: ACPICA: Refuse to evaluate a method if arguments are missing As reported in [1], a platform firmware update that increased the number of method parameters and forgot to update a least one of its callers, caused

    nvd.nist.gov

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.